Newco4Pharmacy Overview

  • Founded
  • 2009
  • Status
  • Public
  • Stock Symbol
  • TNTY
Stock Symbol
  • Investments
  • 2

Newco4Pharmacy General Information


Provider of pharmaceutical products. The company is engaged in the business of production and sale of pharmaceutical products, including specialized compounded pharmaceutical formulations for both the human and veterinary markets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 1355 Peachtree Street
  • Suite 1150
  • Atlanta, GA 30309
  • United States
+1 (844) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Newco4Pharmacy Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Newco4Pharmacy‘s full profile, request access.

Request a free trial

Newco4Pharmacy Executive Team (8)

Name Title Board Seat Contact Info
Louis Deluca Chief Operating Officer
Mack Leath Board Member & Secretary
Casey Gaetano Vice President of Corporate Development
You’re viewing 3 of 8 executive team members. Get the full list »

Newco4Pharmacy Board Members (2)

Name Representing Role Since
0000 00000 Newco4Pharmacy Board Member & Secretary 000 0000
To view Newco4Pharmacy’s complete board members history, request access »

Newco4Pharmacy Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000 00 30-Sep-2016 000000000000000000 00000 Pharmaceuticals 0000000 00000000
Integrity Compounding Pharmacy 09-May-2016 Merger/Acquisition Pharmaceuticals 0000000 00000000
To view Newco4Pharmacy’s complete acquisitions history, request access »

Newco4Pharmacy Subsidiaries (2)

Company Name Industry Location Founded
Integrity Compounding Pharmacy Pharmaceuticals Atlanta, GA 2015
00000000 000000 00 Pharmaceuticals Canton, GA 0000
To view Newco4Pharmacy’s complete subsidiaries history, request access »